Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, COVID-19, Diarrhoea
Clinical narrative: Stomach pain; Diarrhea; This spontaneous case was reported by a physician and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach pain) and DIARRHOEA (Diarrhea) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 025A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension since 1985, Leukoencephalopathy, Hiatus hernia, Lumbar disc disease (L3 to L6), Constipation, Cholesterol, Stress, Dry eyes, Macular degeneration (Minor), Glaucoma and Urination difficulty. Concomitant products included PRUCALOPRIDE SUCCINATE (MOTEGRITY) from 12-Jul-2020 to an unknown date, LACTULOSE from 12-Jul-2020 to an unknown date and MINERAL OIL from 12-Jul-2020 to an unknown date for Constipation, CICLOSPORIN (RESTASIS) for Dry eyes, LATANOPROST for Glaucoma, OMEPRAZOLE for Hiatus hernia, ASCORBIC ACID, POLIGLUSAM (CHITOSAN C) for High cholesterol, CLONIDINE from 10-May-2014 to an unknown date and LABETALOL from 23-Dec-2020 to an unknown date for Hypertension, DIAZEPAM from 02-Aug-2018 to 18-Mar-2021 for Muscle relaxation, MIRTAZAPINE for Stress, TAMSULOSIN for Urination difficulty, VALSARTAN, AMLODIPINE from 08-Oct-2019 to an unknown date, GLUCOSE, POTASSIUM CITRATE, SODIUM CHLORIDE (PEDIALYTE 30) from 18-Jun-2020 to an unknown date, BUPROPION from 06-May-2020 to an unknown date, FISH OIL (FISH OIL OMEGA 3), ICAPS LUTEIN & ZEAXANTHIN FORMULA, LACTOBACILLUS ACIDOPHILUS (PROBIOTIC ACIDOPHILUS [LACTOBACILLUS ACIDOPHILUS]), UBIDECARENONE (CARDIO Q) from 16-Nov-2018 to an unknown date, CALCIUM, INOSITOL, NICOTINIC ACID (NIACIN AND INOSITOL), B COMPLEX SUPER POTENCY, MULTIVITAMINS [VITAMINS NOS], VITAMIN B12 NOS (VITAMIN B 12 [VITAMIN B12 NOS]), VITAMIN D3 and MUPIROCIN for an unknown indication.   On 03-Feb-2021 at 9:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach pain) and DIARRHOEA (Diarrhea). On 04-Feb-2021, DIARRHOEA (Diarrhea) had resolved. At the time of the report, ABDOMINAL PAIN UPPER (Stomach pain) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Nov-2020, COVID-19: negitive (Negative) Negitive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Products known to have been used by the patient, within two weeks prior to the event, included ,amitiya 24 mcg for constipation.  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the event is not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow up information was received included, height, weight, race of the patient.second dose details with events were also added.Medical history/ current conditions , concomitant medications used by the patient were updated in the follow up.